FIELD: veterinary.
SUBSTANCE: invention relates to methods and compositions for reducing specific gravity of urine and reducing a risk index of formation of calcium oxalate in felines. Disclosed is a fodder composition for domestic felines comprising an omega-6-polyunsaturated fatty acid-based additive and an additive based on at least two omega-3-polyunsaturated fatty acids, where the omega-6-polyunsaturated fatty acid-based additive is arachidonic acid (AA) and additives based on at least two omega-3-polyunsaturated fatty acids contain eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in an amount effective to reduce the risk of calcium oxalate (CORI) formation in a feline at least 10 %, wherein contains more additives based on at least two omega-3-polyunsaturated fatty acids compared to the omega-6-polyunsaturated fatty acid-based additive, where the omega-6-polyunsaturated fatty acid-based additive and the additive based on at least two omega-3-polyunsaturated fatty acids are present in amount of 0.3 % to 1 % in terms of the dry weight of the pet food composition, where ratio AA: (EPA + DHA) is in range from 0.1:1 to 0.9:1. Disclosed is a method for increasing the level of hydration of an animal in a feline animal, comprising providing a feline animal family in need thereof, said pet food composition containing an effective amount of an omega-6-polyunsaturated fatty acid-based additive and additives based on at least two omega-3-polyunsaturated fatty acids, to reduce a risk index of forming calcium oxalate (CORI) in said animal felines by at least 10 %. Also disclosed is a method for achieving and maintaining homeostatic levels of hydration of an animal in a feline animal, comprising providing a feline animal family in need thereof, said pet food composition containing an effective amount of an omega-6-polyunsaturated fatty acid-based additive and additives based on at least two omega-3-polyunsaturated fatty acids, to reduce specific gravity of urine and/or risk index of formation of calcium oxalate (CORI) in said animal felines by at least 10 %.
EFFECT: invention corrects the level of body hydration in cats and thus leads to treatment, reduction, inhibition or alleviation of conditions, such as lower urinary tract diseases (FLUTD).
15 cl, 16 dwg, 5 tbl, 5 ex
